Watford, United Kingdom

Brihad Abhyankar

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Brihad Abhyankar

Introduction

Brihad Abhyankar is a notable inventor based in Watford, GB. He has made significant contributions to the field of medicine, particularly in the treatment of complex diseases. With a total of 2 patents to his name, his work is recognized for its innovative approaches and potential impact on patient care.

Latest Patents

Abhyankar's latest patents include a method for treating primary sclerosing cholangitis. This method involves administering an effective amount of a humanized antibody or antigen-binding fragment that specifically targets α4β7 integrin. Another significant patent focuses on predicting the outcome of treatment with an anti-α4β7 integrin antibody. This invention provides methods for identifying patients who are likely to respond positively to therapy involving this antibody.

Career Highlights

Brihad Abhyankar is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research and innovations. His work is pivotal in developing therapies that can improve the quality of life for patients suffering from challenging medical conditions.

Collaborations

Abhyankar collaborates with esteemed colleagues, including Maria Rosario and Timothy L. Wyant. These partnerships enhance the research environment and foster innovative solutions in the pharmaceutical industry.

Conclusion

Brihad Abhyankar's contributions to medical science through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative methods and dedication to research continue to pave the way for advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…